Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZMAT1 mRNA] | CTD | PMID:31150632 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zmat1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZMAT1 mRNA | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZMAT1 mRNA | CTD | PMID:32109520 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZMAT1 mRNA | CTD | PMID:28922406 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZMAT1 mRNA | CTD | PMID:26251327 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZMAT1 mRNA | CTD | PMID:30047161 | aflatoxin B1 | decreases methylation | ISO | ZMAT1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ZMAT1 gene | CTD | PMID:27153756 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ZMAT1 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZMAT1 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | ISO | ZMAT1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZMAT1 5' UTR and Benzo(a)pyrene affects the methylation of ZMAT1 promoter | CTD | PMID:27901495 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of ZMAT1 mRNA | CTD | PMID:31129395 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ZMAT1 mRNA | CTD | PMID:30816183 | carbon nanotube | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | ZMAT1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZMAT1 gene] | CTD | PMID:28238834 | crocidolite asbestos | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of ZMAT1 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ZMAT1 mRNA | CTD | PMID:20106945 | dichloromethane | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Methylene Chloride results in increased expression of ZMAT1 mRNA | CTD | PMID:28392392 | dioxygen | increases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of ZMAT1 mRNA | CTD | PMID:26516004 | dioxygen | multiple interactions | ISO | Zmat1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZMAT1 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | ZMAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMAT1 mRNA | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of ZMAT1 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ZMAT1 mRNA | CTD | PMID:35436446 | fenthion | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Fenthion results in increased expression of ZMAT1 mRNA | CTD | PMID:34813904 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ZMAT1 mRNA | CTD | PMID:33387578 | methidathion | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | methidathion results in increased expression of ZMAT1 mRNA | CTD | PMID:34813904 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ZMAT1 mRNA | CTD | PMID:30047161 | methylmercury chloride | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZMAT1 mRNA | CTD | PMID:28001369 | paracetamol | affects expression | ISO | Zmat1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ZMAT1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZMAT1 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ZMAT1 mRNA | CTD | PMID:26690555 | perfluorohexanesulfonic acid | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZMAT1 mRNA | CTD | PMID:25812627 | perfluorononanoic acid | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ZMAT1 mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZMAT1 mRNA | CTD | PMID:25812627 and PMID:27153767 | perfluorooctanoic acid | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of ZMAT1 mRNA | CTD | PMID:25812627 | phenobarbital | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of ZMAT1 mRNA | CTD | PMID:19270015 | phenobarbital | affects expression | ISO | Zmat1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of ZMAT1 mRNA | CTD | PMID:23091169 | pirinixic acid | multiple interactions | ISO | Zmat1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZMAT1 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ZMAT1 mRNA | CTD | PMID:23811191 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ZMAT1 mRNA | CTD | PMID:30047161 | SB 431542 | multiple interactions | ISO | ZMAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMAT1 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of ZMAT1 mRNA | CTD | PMID:25895662 | sunitinib | increases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ZMAT1 mRNA | CTD | PMID:31533062 | tetrachloromethane | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of ZMAT1 mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZMAT1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ZMAT1 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ZMAT1 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Zmat1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ZMAT1 mRNA | CTD | PMID:23557971 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of ZMAT1 mRNA | CTD | PMID:31129395 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ZMAT1 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ZMAT1 mRNA | CTD | PMID:24935251 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of ZMAT1 mRNA | CTD | PMID:30589522 | triptonide | increases expression | ISO | Zmat1 (Mus musculus) | 6480464 | triptonide results in increased expression of ZMAT1 mRNA | CTD | PMID:33045310 | valproic acid | decreases methylation | ISO | ZMAT1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ZMAT1 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | Zmat1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ZMAT1 mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | ZMAT1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZMAT1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | ZMAT1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZMAT1 mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Cellular Component
Molecular Function
